
|Articles|October 19, 2007
Groups tell Congress to back off fight over ESA dosing decisions
Groups say cancer drug dosing best measured by CMS, Medicaid.
Advertisement
A handful of consumer and health groups have fired the latest salvo in the ongoing battle over Medicare reimbursements for anemia drugs. In a letter sent Wednesday to Congress, the groups-including Consumers Union, U.S. PIRG, the National Research Center for Women & Families, the National Women's Health Network, and the Center for Medical Consumers-urged lawmakers to back off the fight over a CMS
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
3
Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action
4
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
5


























